Trial Profile

Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Dose of SAM-531 Administered Orally To Healthy Young and Elderly Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 04 Dec 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cerlapirdine (Primary)
Indications Alzheimer's disease
Focus Adverse reactions; Pharmacokinetics
Sponsors Wyeth

Most Recent Events

10 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
20 Jan 2009 Status changed from not yet recruiting to recruiting s reported by ClinicalTrials.gov.
20 Jan 2009 Actual initiation date (Aug 2008) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com